Publications by authors named "Gilad Gordon"

Claim this Profile
A
A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy.
Joanne Donovan, Jeffrey A Silverman, Ben Barthel, Michael DuVall, Molly Madden, Gilad Gordon

Muscle Nerve· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.
Joseph Eiden, Gilad Gordon, Carlos Fierro, Renee Herber, Roger Aitchison

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.
Kyriakos P Papadopoulos, Nehal Lakhani, Gerald S Falchook, Gosia Riley, Johan Baeck, Gilad Gordon

Cancer Immunol Immunother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
Paul A Tambyah, Jolene Oon, Rosmonaliza Asli, William Kristanto, Shi-Hsia Hwa, Gilad S Gordon

Vaccine· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial.
Bart Rijnders, Gino J DiSciullo, Botond Csiky, Bolesław Rutkowski, Krzysztof Appelt, Gilad Gordon

Clin Infect Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera, Helen M L Oh, Marsha Raanan, Gilad S Gordon

J Infect Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.
Richard Rupp, Gary Joseph Luckasen, Judith Lee Kirstein, Jorge E Osorio, Joseph D Santangelo, Gilad S Gordon

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.
Jorge E Osorio, Ivan D Velez, Cynthia Thomson, Liliana Lopez, Alejandra Jimenez, Gilad S Gordon

Lancet Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.
Jianqing Lin, Marianna Zahurak, Tomasz M Beer, Charles J Ryan, George Wilding, Gilad Gordon

Urol Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
Shehzad Basaria, Lauren Collins, E Lichar Dillon, Katie Orwoll, Thomas W Storer, Gilad Gordon

J Gerontol A Biol Sci Med Sci· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Phuong Khanh Morrow, Rashmi K Murthy, Joe D Ensor, Gilad S Gordon, Kim A Margolin

Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
Alex A Adjei, Roger B Cohen, Wilbur Franklin, Clive Morris, David Wilson, Gilad Gordon

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis